Among them, IL‐6 is considered the key driver of the hyperinflammatory process in COVID‐19, as supported by a meta‐analysis of six studies demonstrating 2.9‐fold higher mean IL‐6 concentrations in patients with complications of COVID‐19 than in those without complications.5 The gene discussed is IL6; the disease is COVID-19.